|
AVTX | Avalo Therapeutics, Inc. |
|
|
AVTX | Avalo Therapeutics, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.03 |
| Leverage | 28.69% |
| Market Cap | $ 2.5B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -78.3m |
| Margin | 1570.76% |
None